Calcific Uremic Arteriolopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-05-07
Clinical Trial Update: Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy [Phase 3]
A Phase 3 double-blind trial evaluating sodium thiosulfate for pain in calciphylaxis (calcific uremic arteriolopathy) has been withdrawn.